Silencing PLOD2 attenuates cancer stem cell-like characteristics and cisplatin-resistant through Integrin β1 in laryngeal cancer

Laryngeal cancer (LC) is an aggressive malignancy resistant to drug treatments. It has been postulated that cancer stem cells (CSCs) persist in a unique population of cancer cells involved in tumor progression and drug-resistance. In the present study, the effects of PLOD2 expression on ordinary and...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Meiyan, Liu, Xing, Li, Tao, Zhang, Yueqin, Zhao, Xiaoyan, Sun, Wen, Li, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168686/
https://www.ncbi.nlm.nih.gov/pubmed/35660870
http://dx.doi.org/10.1016/j.tranon.2022.101460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168686/
https://www.ncbi.nlm.nih.gov/pubmed/35660870
http://dx.doi.org/10.1016/j.tranon.2022.101460

Ejemplares similares